Carriage of resistant microorganisms in repatriates from foreign hospitals to The Netherlands

被引:44
作者
Kaiser, AM [1 ]
Schultsz, C [1 ]
Kruithof, GJ [1 ]
Debets-Ossenkopp, Y [1 ]
Vandenbroucke-Grauls, C [1 ]
机构
[1] VU Univ, Med Ctr, NL-1007 MB Amsterdam, Netherlands
关键词
antibiotic resistance; colonisation; methicillin-resistant Staphylococcus aureus; repatriated patients; resistance; vancomycin-resistant enterococci;
D O I
10.1111/j.1469-0691.2004.01000.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In a prospective survey conducted between May 1998 and September 2001, the prevalence of carriage of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE) and gentamicin-resistant Gram-negative bacilli (GGNB) was determined in 1167 patients repatriated from foreign hospitals to The Netherlands. Swab specimens, demographic data and clinical data were obtained during transfer of the patients from the foreign hospitals. The total prevalence of carriage of resistant microorganisms was 18.2%. MRSA was carried by 2.7% of all patients, and by 4.7% of the patients repatriated to a Dutch hospital. Antimicrobial treatment (adjusted odds ratio (OR) 3.4; 95% confidence interval (CI) 1.2-9.7), length of stay in a foreign hospital of > 14 days (adjusted OR 5.4; 95% CI 2.3-12) and artificial ventilation (adjusted OR 8.5; 95% CI 1.8-41) were risk factors for carriage of MRSA. VRE and GGNB were isolated from 2.7% and 14.1% of the patients, respectively. Transfer from Asia, and southern, southeastern and eastern Europe, were risk factors for carriage of GGNB. These carriage rates were high compared to those found in patients in Dutch hospitals, where the rates are < 1% for MRSA, 2% for VRE, and 4.5% for GGNB. The highest risk of acquisition of GGNB was associated with the country from where the patient was repatriated, rather than with the antimicrobial treatment received by the individual patient in the foreign hospital.
引用
收藏
页码:972 / 979
页数:8
相关论文
共 33 条
[1]   Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in eight hospitals in Turkey [J].
Aksaray, S ;
Dokuzoguz, B ;
Güvener, E ;
Yücesoy, M ;
Yulug, N ;
Kocagöz, S ;
Ünal, S ;
Çetin, S ;
Calangu, S ;
Günaydin, M ;
Leblebicioglu, H ;
Esen, S ;
Bayar, B ;
Willke, A ;
Findik, D ;
Tuncer, I ;
Baysal, B ;
Günseren, F ;
Mamikoglu, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (05) :695-699
[2]   Methicillin-resistant Staphylococcus aureus:: risk factors for high incidence. [J].
Aubry-Damon, H ;
Soussy, CJ .
REVUE DE MEDECINE INTERNE, 2000, 21 (04) :344-352
[3]   Variation in antibiotic use in the European Union [J].
Cars, O ;
Mölstad, S ;
Melander, A .
LANCET, 2001, 357 (9271) :1851-1853
[4]   PREVALENCE IN SINGAPORE OF ENTEROCOCCI WITH HIGH-LEVEL RESISTANCE TO AMINOGLYCOSIDES AND COMPARISON OF 3 METHODS FOR THEIR DETECTION [J].
CHIEW, YF ;
LIM, SW ;
KUAH, BG ;
LIEW, HY .
JOURNAL OF INFECTION, 1993, 27 (02) :125-131
[5]  
DENEELING AJ, 1997, INF B, V8, P224
[6]  
DENEELING AJ, 1997, INF B, V9, P192
[7]  
Domin M A, 1998, Br J Theatre Nurs, V8, P14
[8]   Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands [J].
Endtz, HP ;
vandenBraak, N ;
vanBelkum, A ;
Kluytmans, JAJW ;
Koeleman, JGM ;
Spanjaard, L ;
Voss, A ;
Weersink, AJL ;
VandenbrouckeGrauls, CMJE ;
Buiting, AGM ;
vanDuin, A ;
Verbrugh, HA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3026-3031
[9]   Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2 [J].
Fridkin, SK ;
Steward, CD ;
Edwards, JR ;
Pryor, ER ;
McGowan, JE ;
Archibald, LK ;
Gaynes, RP ;
Tenover, FC .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :245-252
[10]   Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials [J].
Graffunder, EM ;
Venezia, RA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (06) :999-1005